TRK-820, a selective κ-opioid agonist, produces potent antinociception in cynomolgus monkeys

Japanese Journal of Pharmacology

Volumn 85, Issue 3, 2001, Pages 282-290

  Endoh, T ^a   Tajima, A ^a   Izumimoto, N ^a   Suzuki, T ^a,a   Saitoh, A ^a   Narita, M ^a   Kamei, J ^a   Tseng, L F ^a   Mizoguchi, H ^a   Nagase, H ^a  

^a TORAY INDUSTRIES INC   (Japan)

Author keywords

Antinociceptive effect; Cynomolgus monkey; TRK 820; Opioid agonist; Opioid receptor subtype

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; 3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MORPHINE; NALFURAFINE; NALOXONE; NORBINALTORPHIMINE; PENTAZOCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG INHIBITION; DRUG MEGADOSE; DRUG POTENCY; MALE; MONKEY; NONHUMAN; PRIMATE; RECEPTOR INTRINSIC ACTIVITY; TAIL;

EID: 0035071844     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.85.282     Document Type: Article

References (20)

1. Discovery of a structurally novel opioid κ-agonist derived from 4,5-epoxymorphinan
2. Potent antinociceptive effects of TRK-820, a novel κ-opioid receptor agonist
3. The novel κ-opioid agonist TRK-820 suppresses the rewarding and locomotor-enhancing effects of morphine in mice
4. Blockade of morphine reward through the activation of κ-opioid receptors in mice
5. Evaluation of a kappa opioid agonist, spiradoline, in comparison to morphine and placebo in the oral surgery model
6. Human central nervous system (CNS) effects of a selective kappa opioid agonist
7. A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys
8. Kappa opioids in rhesus monkeys. I. Diuresis, sedation, analgesia and discriminative stimulus effects
9. Kappa opioid antagonist effects of systemically administered nor-binaltorphimine in a thermal antinociception assay in rhesus monkeys
10. U-50,488: A selective and structurally novel non-mu (kappa) opioid agonist
11. Binaltorphimine and nor-binaltorphimine, potent and selective kappa-opioid receptor antagonists
12. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice
13. Characterization of the antinociceptive effects of TRK-820 in the rat
14. Morphine glucuronidation in the rhesus monkey: A comparative in vivo and in vitro study
15. Nor-binaltorphimine: A potent and selective κ-opioid receptor antagonist with long-lasting activity in vivo
16. Extremely long-lasting antagonistic action of nor-binaltorphimine (nor-BNI) in the mouse tail-flick test
17. Pharmacological properties of TRK-820 on cloned μ, δ- and κ-opioid receptors and nociceptin receptor
18. Pharmacologic activity of CI-977, a selective kappa opioid agonist, in rhesus monkeys
19. Behavioral effects of a novel kappa opioid analgesic, U-50488, in rats and rhesus monkeys